Exploring the Causal Relationship Between Inflammatory Bowel Disease and Bell's Palsy Based on Inflammatory Proteins:

Daofeng Fan1, Wenbao Wu2, Jiaqian Dai1

  • 1Department of Neurology, Longyan First Hospital Affiliated to Fujian Medical University, Longyan, Fujian, China.

Brain and Behavior
|August 5, 2025
PubMed
Abstract

Insights

Inflammatory bowel disease (IBD) may genetically increase the risk of Bell's palsy. Specific inflammatory proteins like CXCL5, IL-17C, and SLAMF1 may link these conditions, offering potential therapeutic targets.

Area of Science:

  • Genetics
  • Immunology
  • Gastroenterology

Background:

  • The link between inflammatory bowel disease (IBD) and Bell's palsy is not well-established.
  • This study investigates a potential causal relationship between IBD and Bell's palsy.

Purpose of the Study:

  • To explore the genetic association between IBD and Bell's palsy.
  • To identify shared inflammatory pathways implicated in both conditions.

Main Methods:

  • Utilized two-sample Mendelian randomization (MR) analysis.
  • Employed summary statistics from large-scale Genome-Wide Association Studies (GWAS) for Bell's palsy, IBD, and 91 inflammatory proteins.

Main Results:

  • A significant genetic correlation was found between IBD and Bell's palsy (OR: 1.13).
  • Crohn's disease also showed a significant association with Bell's palsy (OR: 1.10).
  • CXCL5, IL-17C, and SLAMF1 were identified as potential shared inflammatory mediators.

Conclusions:

  • Genetic evidence suggests IBD may be a risk factor for Bell's palsy.
  • CXCL5, IL-17C, and SLAMF1 represent potential therapeutic targets for both IBD and Bell's palsy.
  • Findings may inform novel treatment strategies for these distinct conditions.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
420
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
383
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
388